Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) This study shows that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results